DOI: 10.1055/s-00000017

Experimental and Clinical Endocrinology & Diabetes

Referenz

Hammes HP, Du X, Edelstein D. et al.
Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy.

Nat Med 2003;
9: 294-299 doi:10.1038/nm834

Hammes HP, Du X, Edelstein D. et al.
Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy.

Nat Med 2003;
9: 294-299 doi:10.1038/nm834

Bibliographische Angaben herunterladen

Suchen in:
Aufrufen in: